The Thomson Corporation has acquired Newport Strategies, Inc., a provider of competitive intelligence for the pharmaceutical industry. Terms of the transaction were not disclosed. Newport Strategies will become part of the scientific business within the Thomson Scientific and Healthcare market group. Newport offers databases and consulting solutions to drug manufacturers. Generic pharmaceutical companies use Newport's Horizon Global intelligence system to find business development and licensing opportunities, target products for internal development, and identify strategic suppliers of active pharmaceutical ingredients.